These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 16286413

  • 1. Resection of an orbital lymphangioma with the aid of an intralesional liquid polymer.
    Malhotra AD, Parikh M, Garibaldi DC, Merbs SL, Miller NR, Murphy K.
    AJNR Am J Neuroradiol; 2005; 26(10):2630-4. PubMed ID: 16286413
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [A variety of orbital lymphangioma treatments: one case treated with orbital decompression therapy and the other case with intralesional injection of OK-432 therapy].
    Oyama T, Eguchi K, Cho H, Abe H.
    Nippon Ganka Gakkai Zasshi; 2009 Jul; 113(7):732-40. PubMed ID: 19637816
    [Abstract] [Full Text] [Related]

  • 4. Successful treatment of orbital lymphangioma with intralesional bleomycin and application of continuous negative pressure.
    Lee KH, Han SH, Yoon JS.
    Korean J Ophthalmol; 2015 Feb; 29(1):70-2. PubMed ID: 25646065
    [No Abstract] [Full Text] [Related]

  • 5. Sclerotherapy for Orbital Lymphangioma - Case Series and Literature Review.
    Patel KC, Kalantzis G, El-Hindy N, Chang BY.
    In Vivo; 2017 Feb; 31(2):263-266. PubMed ID: 28358710
    [Abstract] [Full Text] [Related]

  • 6. Sclerosing therapy for orbital lymphangioma using sodium tetradecyl sulfate.
    Poonyathalang A, Preechawat P, Jiarakongmun P, Pongpech S.
    Jpn J Ophthalmol; 2008 Feb; 52(4):298-304. PubMed ID: 18773268
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Intralesional injection of OK-432 for vision-threatening orbital lymphangioma.
    Yoon JS, Choi JB, Kim SJ, Lee SY.
    Graefes Arch Clin Exp Ophthalmol; 2007 Jul; 245(7):1031-5. PubMed ID: 17577592
    [Abstract] [Full Text] [Related]

  • 14. Orbital Lymphangioma: Characteristics and Treatment Outcomes of 12 Cases.
    Woo YJ, Kim CY, Sgrignoli B, Yoon JS.
    Korean J Ophthalmol; 2017 Jun; 31(3):194-201. PubMed ID: 28534344
    [Abstract] [Full Text] [Related]

  • 15. [Orbital lymphangioma: a clinical and radiological entity. Apropos of a case].
    Lewden O, Garcher C, Desvaux C, Couailler JF, Bron A.
    J Fr Ophtalmol; 1995 Jun; 18(1):56-9. PubMed ID: 7738298
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Conservative management of childhood orbital lymphangioma.
    Wilson ME, Parker PL, Chavis RM.
    Ophthalmology; 1989 Apr; 96(4):484-9. PubMed ID: 2726177
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.